Virginia · 2025 Regular Session · Bill
HB 2144: Drug Control Act; manufacturers, wholesale distributors, etc., annual report.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 2144 is a bill introduced in the Virginia House on January 7, 2025. According to its official title, it concerns: Drug Control Act; manufacturers, wholesale distributors, etc., annual report. Primary sponsor: Paul V. Milde. Most recent recorded action (February 5, 2025): Left in Labor and Commerce.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Drug Control Act; manufacturers, wholesale distributors, and medical equipment suppliers; annual report. Requires a manufacturer, wholesale distributor, or medical equipment supplier that is licensed, permitted, or registered with the Board of Pharmacy to submit an annual report of the amount such manufacturer, wholesale distributor, or medical equipment supplier spent during the preceding year on direct-to-consumer advertising of each prescription drug or device.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Paul V. Milde | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Left in Labor and Commerce
- Fiscal Impact Statement from Department of Planning and Budget (HB2144)
- Referred to Committee on Labor and Commerce
- Prefiled and ordered printed; Offered 01-13-2025 25101868D